Consistent with previous studies demonstrating the ligand function of RNase1 in EphA4 in breast cancer cells23, our data demonstrated that RNase1 phosphorylated EphA4 and ERK1/2 in two HCC cell lines (Supplementary Fig. 2h, i). Here, MAPK3 is linked to hepatocellular carcinoma.